The deal is estimated to bring in $2 billion in operational synergies, in addition to further commercializing Allergan's products outside the US.
The American Medical Association voted in support of banning DTC advertising.
Some pharma companies are taking steps to address concerns about the high prices of drugs at a time when Democratic lawmakers are urging price controls.
If more physicians begin participating in late-phase research efforts—and work to educate patients about these opportunities—we can expect new innovations in treatment solutions to come more quickly to market.
Although the industry wants to help patients get healthy - and wants to be a critical part in that process - there's a delicate balance to strike between selling product and achieving healthier outcomes.
Soon, IBM says, Watson will be used by one particular pharma company to create a website where, once a drug is prescribed, patients can ask questions in their own words and the website will provide answers in near real-time.